TAP Block With Liposomal Bupivacaine Versus Pre-incisional Wound Infiltration With Bupivacaine for Postoperative Pain

• Status: Terminated
• Trial end date: 2016-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

In this randomized, controlled, double-blinded trial we plan to evaluate post-operative pain relief after laparoscopic-assisted Transversus Abdominis Plane (TAP) block using liposomal bupivacaine plus bupivacaine versus pre-incisional would infiltration with bupivacaine in patients undergoing Total laparoscopic or robotic assisted laparoscopic hysterectomy.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Tennessee
• Treatments: Bupivacaine; Ketorolac; Ketorolac Tromethamine

Criteria

Inclusion Criteria:

• ASA physical status 1-3,

• Scheduled for laparoscopic or robotic assisted laparoscopic hysterectomy,

• Able to participate personally or by legal representation in informed consent

Exclusion Criteria:

• History of relevant allergy to the study drugs (Bupivacaine),

• Chronic opioid use or drug abuse history,

• Inability to understand the study protocol,

• Refusal to provide written consent,

• Soft tissue infection of the abdominal wall and skin